• Applied Protocols with 5,6-Dichloro-1-β-D-ribofuranosylbenzi

  2026-06-12

  Harness the translational power of 5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) to precisely modulate transcriptional elongation, enabling robust workflows from cell fate engineering to antiviral research. This guide distills experimental insights, reference breakthroughs, and practical troubleshooting for maximizing DRB’s impact in high-fidelity assays.

• One-step TUNEL FITC Apoptosis Detection Kit: Precision in DN

  2026-06-11

  The One-step TUNEL FITC Apoptosis Detection Kit empowers researchers to detect apoptosis with high specificity in both cultured cells and tissue sections. Its streamlined protocol and robust FITC-labeled dUTP incorporation facilitate reproducible quantification across cancer, neurodevelopmental, and toxicology studies.

• 0.4% Trypan Blue Solution: Technical Guide for Cell Viabilit

  2026-06-11

  0.4% Trypan Blue Solution offers a direct method for distinguishing live from dead cells in suspension, addressing the need for rapid, reproducible cell viability measurement in research workflows. It is best suited for standard cell counting and cytotoxicity assays, but not for clinical diagnostics or multiparametric applications requiring higher sensitivity or multiplexing.

• STAT2 Coiled-Coil Degron Drives Zika Virus Interferon Evasio

  2026-06-10

  Parisien et al. elucidate how Zika virus NS5 targets a degron within the STAT2 coiled-coil domain for proteasomal degradation, thereby disabling interferon signaling. These findings clarify a key mechanism of viral immune evasion and offer new leads for therapeutic intervention.

• TSPAN18 Stabilizes STIM1 to Drive Prostate Cancer Bone Metas

  2026-06-10

  Zhou et al. (2023) reveal that TSPAN18 protects STIM1 from TRIM32-mediated ubiquitination, promoting store-operated calcium entry (SOCE) and accelerating bone metastasis in prostate cancer. This mechanistic insight identifies potential molecular targets within the calcium signaling pathway for therapeutic intervention.

• EZ Cap™ EPO mRNA (ψUTP): Advancing mRNA Stability & Neurorep

  2026-06-09

  Discover how EZ Cap™ EPO mRNA (ψUTP) unlocks next-generation human erythropoietin mRNA research through superior stability, capping, and translational efficiency. This in-depth analysis reveals unique mechanistic insights and strategic assay guidance beyond existing resources.

• MEG3 Modulation of TGF-β1/PI3K/AKT in NiO NP-Induced Lung Fi

  2026-06-09

  The reference study uncovers how downregulation of lncRNA MEG3 contributes to pulmonary fibrosis following nickel oxide nanoparticle (NiO NP) exposure, acting via enhanced TGF-β1 expression and PI3K/AKT pathway activation. Importantly, the work demonstrates that the ALK5 inhibitor SB 431542 can suppress this profibrotic signaling, providing a mechanistic link and potential intervention strategy.

• FAISL lncRNA Blocks FAK Proteolysis to Drive TNBC Progressio

  2026-06-08

  The reference study identifies the long noncoding RNA FAISL as a direct regulator of FAK protein stability in triple negative breast cancer (TNBC). By inhibiting Calpain 2-mediated FAK proteolysis, FAISL promotes tumor adhesion, proliferation, and metastasis, highlighting a novel mechanism and potential therapeutic target in aggressive breast cancer.

• Epigenetic Dynamics and Vesicle Release in Shrimp Hemocyte I

  2026-06-08

  This study reveals that shrimp hemocytes exhibit rapid, dose-dependent histone modifications and extracellular vesicle release following priming with inactivated Vibrio parahaemolyticus. These findings establish a baseline for understanding epigenetic and vesicular mechanisms underlying innate immune regulation in crustaceans, offering new directions for disease resilience research in aquaculture.

• Cisplatin (CDDP): Mechanistic Depth and Emerging Research Fr

  2026-06-07

  Explore the advanced mechanistic roles of Cisplatin (CDDP) in cancer research, with a focus on DNA crosslinking, apoptosis pathways, and new insights into RNA methylation and DNA repair. This article extends beyond conventional discussions to inform experimental design and chemoresistance studies.

• S-Adenosylmethionine in CNS Methylation: Protocols and Pitfa

  2026-06-06

  Harness S-adenosylmethionine (Ademetionine) to drive precision in methylation assays, epigenetic studies, and central nervous system disorder models. This article delivers actionable experimental protocols, troubleshooting strategies, and translational insights grounded in data-rich literature and product expertise.

• Bergenin Targets γδT17 Cells in Psoriasis via PPARγ-PROX1 Ax

  2026-06-05

  This study uncovers how bergenin, a natural PPARγ agonist from Bergenia purpurascens, selectively suppresses pathogenic γδT17 cells to ameliorate psoriasis. By elucidating a PPARγ-mediated mechanism that degrades PROX1 and inhibits IL-17A production, the findings advance our understanding of metabolic and transcriptional control in psoriatic inflammation.

• Zoledronic Acid: Optimizing Cancer Cell Apoptosis & Bone Dis

  2026-06-05

  Zoledronic Acid, a nitrogen-containing bisphosphonate, empowers research on cancer cell apoptosis and bone disease prevention through rigorously validated protocols. Explore advanced use-cases, stepwise workflows, and actionable troubleshooting tips to maximize experimental reliability and translational insight.

• Zosuquidar (LY335979) for Multidrug Resistance Reversal in C

  2026-06-04

  Zosuquidar (LY335979) 3HCl enables researchers to directly reverse P-glycoprotein-mediated multidrug resistance (MDR), restoring chemotherapeutic efficacy in resistant cancer models. This guide translates cutting-edge mechanistic insights and experimental protocols into actionable workflows, with troubleshooting tips to maximize impact in both preclinical and translational oncology research.

• Ampicillin Sodium: Mechanistic Insight and Translational Lev

  2026-06-04

  This thought-leadership article explores how Ampicillin sodium, a β-lactam antibiotic, underpins translational advances in antibacterial research. We blend mechanistic rationale, experimental best practices, and competitive benchmarking—anchored by new comparative data and actionable guidance for researchers seeking to optimize efficacy in both in vitro and in vivo antibacterial studies.

8531 records 11/569 page Previous Next First page 上5页 1112131415 下5页 Last page